These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Secular trends in the epidemiology of Clostridium difficile infection (CDI): relationship with alcohol gel and antimicrobial usage in a hospital. Silva M; Marra AR; Camargo TZ; Almeida SM; Siqueira I; Correa L; Kawagoe JY; dos Santos OF; Edmond MB Int J Infect Dis; 2013 Jun; 17(6):e418-21. PubMed ID: 23419978 [TBL] [Abstract][Full Text] [Related]
44. [Clostridium difficile-associated infections in a septic ward of a level 1 trauma centre: an analysis of 159 patients]. Citak M; Backhaus M; Dogan A; Aach M; Schildhauer TA; Fehmer T Z Orthop Unfall; 2012 Feb; 150(1):62-6. PubMed ID: 22065373 [TBL] [Abstract][Full Text] [Related]
45. Proton Pump Inhibitors and the Risk for Hospital-Acquired Clostridium difficile Infection. Barletta JF; El-Ibiary SY; Davis LE; Nguyen B; Raney CR Mayo Clin Proc; 2013 Oct; 88(10):1085-90. PubMed ID: 24012413 [TBL] [Abstract][Full Text] [Related]
46. Lessons learned from implementing Clostridium difficile-focused antibiotic stewardship interventions. Ostrowsky B; Ruiz R; Brown S; Chung P; Koppelman E; van Deusen Lukas C; Guo Y; Jalon H; Sumer Z; Araujo C; Sirtalan I; Brown C; Riska P; Currie B Infect Control Hosp Epidemiol; 2014 Oct; 35 Suppl 3():S86-95. PubMed ID: 25222903 [TBL] [Abstract][Full Text] [Related]
47. The incidence of nosocomial toxigenic clostridium difficile associated diarrhea in Tehran tertiary medical centers. Sadeghifard N; Salari MH; Ghassemi MR; Eshraghi S; Amin Harati F Acta Med Iran; 2010; 48(5):320-5. PubMed ID: 21287466 [TBL] [Abstract][Full Text] [Related]
48. Incidence and risk factors for hospital-acquired Clostridium difficile infection among inpatients in an orthopaedic tertiary care hospital. Campbell KA; Phillips MS; Stachel A; Bosco JA; Mehta SA J Hosp Infect; 2013 Feb; 83(2):146-9. PubMed ID: 23313026 [TBL] [Abstract][Full Text] [Related]
49. Excess length of stay and mortality due to Clostridium difficile infection: a multi-state modelling approach. van Kleef E; Green N; Goldenberg SD; Robotham JV; Cookson B; Jit M; Edmunds WJ; Deeny SR J Hosp Infect; 2014 Dec; 88(4):213-7. PubMed ID: 25441017 [TBL] [Abstract][Full Text] [Related]
50. Incidence of polymerase chain reaction-diagnosed Clostridium difficile in a large high-risk cohort, 2011-2012. Tartof SY; Yu KC; Wei R; Tseng HF; Jacobsen SJ; Rieg GK Mayo Clin Proc; 2014 Sep; 89(9):1229-38. PubMed ID: 25064782 [TBL] [Abstract][Full Text] [Related]
51. Incidence and mortality associated with Clostridium difficile infection at a Japanese tertiary care center. Honda H; Yamazaki A; Sato Y; Dubberke ER Anaerobe; 2014 Feb; 25():5-10. PubMed ID: 24184291 [TBL] [Abstract][Full Text] [Related]
52. Lack of increased colonization with vancomycin-resistant enterococci during preferential use of vancomycin for treatment during an outbreak of healthcare-associated Clostridium difficile infection. Miller M; Bernard L; Thompson M; Grima D; Pepin J Infect Control Hosp Epidemiol; 2010 Jul; 31(7):710-5. PubMed ID: 20518636 [TBL] [Abstract][Full Text] [Related]
53. C. difficile infection (CDI) in a long-term acute care facility (LTAC). Goldstein EJ; Polonsky J; Touzani M; Citron DM Anaerobe; 2009 Dec; 15(6):241-3. PubMed ID: 19683064 [TBL] [Abstract][Full Text] [Related]
54. A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies. Parmar SR; Bhatt V; Yang J; Zhang Q; Schuster M J Oncol Pharm Pract; 2014 Jun; 20(3):172-82. PubMed ID: 23804627 [TBL] [Abstract][Full Text] [Related]
55. Clostridium difficile infection in older adults: a review and update on its management. Kee VR Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856 [TBL] [Abstract][Full Text] [Related]
56. Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001-2006. Kim J; Smathers SA; Prasad P; Leckerman KH; Coffin S; Zaoutis T Pediatrics; 2008 Dec; 122(6):1266-70. PubMed ID: 19047244 [TBL] [Abstract][Full Text] [Related]
58. The changing epidemiology of Clostridium difficile infection. Honda H; Dubberke ER Curr Opin Gastroenterol; 2014 Jan; 30(1):54-62. PubMed ID: 24285002 [TBL] [Abstract][Full Text] [Related]
59. Risk factors for severity and relapse of pseudomembranous colitis in an elderly population. Moshkowitz M; Ben-Baruch E; Kline Z; Shimoni Z; Niven M; Konikoff F Colorectal Dis; 2007 Feb; 9(2):173-7. PubMed ID: 17223943 [TBL] [Abstract][Full Text] [Related]
60. Length of stay and mortality due to Clostridium difficile infection acquired in the intensive care unit. Dodek PM; Norena M; Ayas NT; Romney M; Wong H J Crit Care; 2013 Aug; 28(4):335-40. PubMed ID: 23337482 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]